Literature DB >> 17617858

Steroid avoidance regimens: a comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode.

A Humar1, K Gillingham, R Kandaswamy, W Payne, A Matas.   

Abstract

Roughly 15% of kidney transplant recipients on a rapid discontinuation of prednisone (RDP) protocol have > or =1 episode of acute rejection (AR). One clinically important question is whether long-term maintenance steroids should be introduced in those recipients having AR. Of 842 adult kidney transplant recipients on an RDP protocol, 149 (17.7%) have had at least 1 AR episode. Of these, 51 (34%) started on maintenance prednisone (5 mg/day) after treatment of the AR, while 98 (66%) remained steroid free. Demographics for the two groups were similar. With mean follow-up of 26 months, 48 (32%) of the recipients have had a 2nd AR episode: 15 (29.4%) in those on maintenance steroids vs. 33 (33.7%) in those remaining steroid free (p = 0.12). Graft survival was not significantly different between the two groups. Multivariate analysis of risk factors for a 2nd episode found the histologic appearance of the initial AR episode to be the most significant risk factor. But, whether steroids were added to the maintenance regimen or not, also seemed to have an impact (RR = 2.1, p = 0.07). At present there is evidence to suggest that some SA patients should start on maintenance steroids after AR. However, longer follow-up with more patients is necessary.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617858     DOI: 10.1111/j.1600-6143.2007.01883.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  16 in total

1.  Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation.

Authors:  Michael D Rizzari; Thomas M Suszynski; Kristen J Gillingham; Ty B Dunn; Hassan N Ibrahim; William D Payne; Srinath Chinnakotla; Erik B Finger; David E R Sutherland; Raja Kandaswamy; John S Najarian; Timothy L Pruett; Aleksandra Kukla; Richard Spong; Arthur J Matas
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

2.  Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation.

Authors:  T M Suszynski; K J Gillingham; M D Rizzari; T B Dunn; W D Payne; S Chinnakotla; E B Finger; D E R Sutherland; J S Najarian; T L Pruett; A J Matas; R Kandaswamy
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

3.  Early steroid withdrawal in repeat kidney transplantation.

Authors:  Muhammad A Mujtaba; Tim E Taber; William C Goggins; Muhammad S Yaqub; Dennis P Mishler; Martin L Milgrom; Jonathan A Fridell; Andrew Lobashevsky; John A Powelson; Asif A Sharfuddin
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 8.237

4.  Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes From the University of Minnesota.

Authors:  Oscar Kenneth Serrano; Raja Kandaswamy; Kristen Gillingham; Srinath Chinnakotla; Ty B Dunn; Erik Finger; William Payne; Hassan Ibrahim; Aleksandra Kukla; Richard Spong; Naim Issa; Timothy L Pruett; Arthur Matas
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

Review 5.  Minimization of steroids in kidney transplantation.

Authors:  Arthur J Matas
Journal:  Transpl Int       Date:  2008-07-24       Impact factor: 3.782

Review 6.  Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?

Authors:  Fu L Luan; Diane E Steffick; Akinlolu O Ojo
Journal:  Kidney Int       Date:  2009-07-22       Impact factor: 10.612

Review 7.  Steroid elimination-who, when, how?

Authors:  A J Matas
Journal:  Transplant Proc       Date:  2008-12       Impact factor: 1.066

Review 8.  Metabolic consequences of modern immunosuppressive agents in solid organ transplantation.

Authors:  Oluwatoyin Bamgbola
Journal:  Ther Adv Endocrinol Metab       Date:  2016-03-30       Impact factor: 3.565

9.  Steroid-free immunosuppression in pediatric renal transplantation: rationale for and [corrected] outcomes following conversion to steroid based therapy.

Authors:  Scott Sutherland; Li Li; Waldo Concepcion; Oscar Salvatierra; Minnie M Sarwal
Journal:  Transplantation       Date:  2009-06-15       Impact factor: 4.939

10.  Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression.

Authors:  F L Luan; D E Steffick; C Gadegbeku; S P Norman; R Wolfe; A O Ojo
Journal:  Am J Transplant       Date:  2008-10-24       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.